重要なことは経験です。 その理由をご覧ください。
お気軽にお問い合わせください。
No-No’s in Drug Safety
An overview covering a number of things to avoid doing when it comes to drug safety.
Read More
Different Regulatory Actions from Different Agencies
Bart Cobert explores the potential reasons for the differing regulatory actions from the different agencies.
Read More
医薬品安全性監視と薬の安全性における看護師の貢献
Dr. Adele Mueller explores the strong patient safety and advocacy responsibility of nurses who work in the pharmaceutical industry.
Read More
データ報告の是非
Bart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.
Read More
医療用大麻と薬の安全性
Bart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.
Read More
シグナル検出とシグナル管理
Dr. W. Mark Riddle, M.D explores signal detection and signal management in Pharmacovigilance.
Read More
因果関係評価ガイド
What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.
Read More
Artificial Intelligence in Healthcare – Potential Use Cases
The greatest change AI will bring about in healthcare is the enabling of clinicians to make sense of the mind-boggling amount of patient data being generated every day.
Read More
英国および欧州医薬品庁の2019年最新情報
Bart Cobert reviews the changes and updates happening with UK and EMA inspections.
Read More
音声対話―健康転帰向上の伝達手段
Voice Assistants may just be the key to solving the challenge of patient non-compliance.
Read More
